Longitudinal Analysis of the Effect of Repeated Transarterial Chemoembolization for Liver Cancer on Portal Venous Pressure

被引:0
作者
Frangakis, Constantine [1 ]
Sohn, Jae Ho [2 ]
Bas, Ahmet [2 ,3 ]
Chapiro, Julius [2 ,4 ]
Schernthaner, Ruediger E. [2 ]
Lin, MingDe [2 ,4 ]
Hamilton, James P. [5 ]
Pawlik, Timothy M. [6 ]
Hong, Kelvin [2 ]
Duran, Rafael [2 ,7 ,8 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA
[2] Johns Hopkins Univ Hosp, Russell H Morgan Dept Radiol & Radiol Sci, Div Vasc & Intervent Radiol, Baltimore, MD 21287 USA
[3] Istanbul Univ, Dept Radiol, Cerrahpasa Med Sch, Istanbul, Turkey
[4] Yale Univ, Sch Med, Dept Radiol & Biomed Imaging, New Haven, CT USA
[5] Johns Hopkins Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD USA
[6] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA
[7] Lausanne Univ Hosp, Dept Radiol & Intervent Radiol, Lausanne, Switzerland
[8] Univ Lausanne, Lausanne, Switzerland
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
portal hypertension; longitudinal data analysis; transarterial chemoembolization; TACE; hepatocellular carcinoma; HCC; variceal bleeding; TRANSCATHETER ARTERIAL EMBOLIZATION; COUNT/SPLEEN DIAMETER RATIO; HEPATOCELLULAR-CARCINOMA; ESOPHAGEAL-VARICES; SPLENIC VOLUME; HYPERTENSION; CIRRHOSIS; HEMODYNAMICS; CT; COMPLICATIONS;
D O I
10.3389/fonc.2021.639235
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectivesInvestigate long-term effects of repeated transarterial chemoembolization (TACE) on portal venous pressure (PVP) using non-invasive surrogate markers of portal hypertension. MethodsRetrospective, Institutional Review Board-approved study. 99 patients [hepatocellular carcinoma (HCC) group (n=57); liver metastasis group (n=42)] who underwent 279TACEs and had longitudinal pre-/post-therapy contrast-enhanced-MRI (n=388) and complete blood work were included. Outcomes of interest were platelet count (PC), spleen volume, ascites and portosystemic collaterals. Variables included TACE type/number, tumor type, microcatheter location, Child-Pugh, baseline tumor burden (tumor number/total/largest size), vessel invasion, alpha-fetoprotein, Eastern Cooperative Oncology Group (ECOG) performance status, and Model for End-Stage Liver Disease (MELD) score. Generalized Estimating Equations assessed the associations between TACE and outcomes. Power analysis determined the sample size was sufficient. ResultsNo significant change in PC over time was observed in either groups, regardless of liver function (P>0.05). Baseline spleen volume was 226 cm(3) for metastatic group, and was larger by 204 cm(3) for HCC group (P<0.001). Spleen volume increased by 20 cm(3) (95%CI: 8-32; P=0.001) for both groups after 1(st)TACE and by 16cm(3)/TACE (P=0.099) over the full follow-up (up to 9TACEs). Spleen volume also tended to increase by 23cm(3) (95%CI: -1-48; P=0.064) with higher tumor burden. Odds of developing moderate/severe ascites for metastatic patients was decreased by 0.5 (95%CI: 0.3-0.9; P=0.014), regardless of the Child-Pugh, and increased by 1.5 (95%CI: 1.2-1.9; P<0.001) among HCC patients with unstable Child-Pugh, whereas no change was noted with stable Child-Pugh. HCC patients with unstable Child-Pugh demonstrated a significant increase in portosystemic collaterals number over time (P=0.008). PVP-related complications such as variceal bleeding post-TACE were low (0.4%). ConclusionRepeated TACEs did seem to have an impact on PVP. However, the increase in PVP had marginal effects with low portal hypertension-related complications.
引用
收藏
页数:11
相关论文
共 40 条
  • [1] Thrombocytopenia associated with chronic liver disease
    Afdhal, Nezam
    McHutchison, John
    Brown, Robert
    Jacobson, Ira
    Manns, Michael
    Poordad, Fred
    Weksler, Babette
    Esteban, Rafael
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 (06) : 1000 - 1007
  • [2] Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis
    Berzigotti, Annalisa
    Seijo, Susana
    Arena, Umberto
    Abraldes, Juan G.
    Vizzutti, Francesco
    Garcia-Pagan, Juan Carlos
    Pinzani, Massimo
    Bosch, Jaime
    [J]. GASTROENTEROLOGY, 2013, 144 (01) : 102 - U206
  • [3] ULTRASONOGRAPHY IN THE DIAGNOSIS OF PORTAL-HYPERTENSION - DIMINISHED RESPONSE OF PORTAL VESSELS TO RESPIRATION
    BOLONDI, L
    GANDOLFI, L
    ARIENTI, V
    CALETTI, GC
    CORCIONI, E
    GASBARRINI, G
    LABO, G
    [J]. RADIOLOGY, 1982, 142 (01) : 167 - 172
  • [4] The clinical use of HVPG measurements in chronic liver disease
    Bosch, Jaime
    Abraldes, Juan G.
    Berzigotti, Annalisa
    Carlos Garcia-Pagan, Juan
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (10) : 573 - 582
  • [5] INFLUENCE OF THE DEGREE OF LIVER-FAILURE ON SYSTEMIC AND SPLANCHNIC HEMODYNAMICS AND ON RESPONSE TO PROPRANOLOL IN PATIENTS WITH CIRRHOSIS
    BRAILLON, A
    CALES, P
    VALLA, D
    GAUDY, D
    GEOFFROY, P
    LEBREC, D
    [J]. GUT, 1986, 27 (10) : 1204 - 1209
  • [6] Cirrhosis: CT and MR imaging evaluation
    Brancatelli, Giuseppe
    Federle, Michael P.
    Ambrosini, Roberta
    Lagalla, Roberto
    Carriero, Alessandro
    Midiri, Massimo
    Vilgrain, Valrie
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2007, 61 (01) : 57 - 69
  • [7] A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma
    Chan, AO
    Yuen, MF
    Hui, CK
    Tso, WK
    Lai, CL
    [J]. CANCER, 2002, 94 (06) : 1747 - 1752
  • [8] Gastrointestinal bleeding in cirrhotic patients with hepatocellular carcinoma undergoing intrahepatic artery chemotherapy
    Desautels, SG
    Slivka, A
    Schoen, RE
    Carr, B
    Rabinovitz, M
    Silverman, W
    [J]. GASTROINTESTINAL ENDOSCOPY, 1997, 46 (05) : 430 - 434
  • [9] Transcatheter arterial chemoembolization for hepatocellular carcinoma in cirrhosis: influence on portal hypertension
    Elia, Chiara
    Venon, Wilma Debernardi
    Stradella, Davide
    Martini, Silvia
    Brunello, Franco
    Marzano, Alfredo
    Saracco, Giorgio
    Rizzetto, Mario
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (07) : 573 - 577
  • [10] European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019